Skip to main navigation

Arrowhead

  • About
    • Overview
    • Management
    • Board of Directors
    • Scientific Advisors
  • Pipeline
    • Overview
    • ARO-AAT
    • ARO-APOC3
    • ARO-ANG3
    • ARO-HSD
    • ARO-ENaC
    • ARO-HIF2
    • JNJ-3989
    • AMG 890
    • ARO-JNJ1
  • Science
    • Overview
    • Publications
  • News and Events
  • Investors

    Investor Relation menu header

    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
    • Stock Information
      • Historic Stock Lookup
      • Stock Splits
      • Analyst Coverage
      • Ownership Profile
    • Investor FAQs
    • Contact Us
  • Careers
  • Contact

Arrowhead Pharmaceuticals 2021 Third Quarter Results

Investors

Investor Relations

  • Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
  • Stock Information
  • Investor FAQs
  • Contact Us

Arrowhead Pharmaceuticals 2021 Third Quarter Results

Aug 5, 2021 4:30 PM EDT

Listen to webcast

Supporting Materials

Prepared Remarks 178.2 KB

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Shareholder Tools

  • Email Alerts Subscription
  • Download Library
  • RSS News Feeds
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter
  • RSS
  • Sitemap
  • Privacy Policy
  • Terms of Use
  • Follow Us:
Copyright © Arrowhead Pharmaceuticals, Inc. Website Design by Mentus